Cloning and characterisation of the first drug-metabolising canine UDP-glucuronosyltransferase of the 2B subfamily

Biochemical Pharmacology

Volumn 65, Issue 8, 2003, Pages 1251-1259

  Soars, Matthew G ^a,c   Fettes, Michelle ^a   O'Sullivan, Audrey C ^a   Riley, Robert J ^b   Ethell, Brian T ^a   Burchell, Brian ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Dog UGT2B31; Morphine glucuronidation; Rat UGT2B1; UDP glucuronosyltransferase; UGT activity; UGT2B7

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; GLUCURONOSYLTRANSFERASE; MORPHINE 3 GLUCURONIDE; OPIATE; PHENOL DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CHINESE HAMSTER; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; DOG; DRUG DETOXIFICATION; GENE ISOLATION; GENE SEQUENCE; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INFORMATION; KINETICS; LIVER MICROSOME; LUNG FIBROBLAST; MASS SPECTROMETRY; METABOLISM; MOLECULAR CLONING; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RAT; SEQUENCE ALIGNMENT;

EID: 0037446386     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00064-9     Document Type: Article

References (24)

1. Dutton GJ. Glucuronidation of drugs and other compounds. Boca Raton: CRC Press; 1980.
2. Clarke DJ, Buchell B. The uridine diphosphate glucuronosyltransferase multigene family: function and regulation. In: Frederic C, Kaufsan FC, editors. Handbook of experimental pharmacology. New York: Springer; 1994. p. 3-43.
3. Li A.P. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov. Today. 6:2001;357-366.
4. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Bélanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Chowdhury J.R., Ritter J.K., Schachter H., Tephly T.R., Tipton K.F., Nebert D.W. The UDP glycosyltransferase gene superfamily: recommended nomenclature based on evolutionary divergence. Pharmacogenetics. 7:1997;255-269.
5. Coffman B.L., Rios G.R., King C.D., Tephly T.R. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab. Dispos. 25:1997;1-4.
6. Jin C., Miners J.O., Lillywhite K.J., Mackenzie P.I. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J. Pharmacol. Exp. Ther. 264:1993;475-479.
7. Barbier O., Turgeon D., Girard C., Green M.D., Tephly T.R., Hum D.W., Bélanger A. 3′-Azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab. Dispos. 28:2000;497-502.
8. Ethell B.T., Beaumont K., Rance D.J., Burchell B. Use of cloned and expressed human UDP-glucuronosyltransferases for the assessment of human drug conjugation and identification of potential drug interactions. Drug Metab. Dispos. 29:2001;48-53.
9. Soars M.G., Riley R.J., Findlay K.A.B., Coffey M.J., Burchell B. Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney. Drug Metab. Dispos. 29:2001;121-126.
10. Soars M.G., Riley R.J., Burchell B. Evaluation of the marmoset as a model species for drug glucuronidation. Xenobiotica. 31:2001;849-860.
11. Soars M.G., Smith D.J., Riley R., Burchell B. Cloning and characterization of a canine UDP-glucuronosyltransferase. Arch. Biochem. Biophys. 391:2001;218-224.
12. Feinberg AP, Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity" (addendum to Vol. 132, p. 6-13, 1983). Anal Biochem 1984;137:266-7.
13. Coughtrie M.W.H., Burchell B., Shepherd I.M., Bend J.R. Defective induction of phenol glucuronidation by 3-methylcholanthrene in Gunn rats is due to the absence of a specific UDP-glucuronosyltransferase isoenzyme. Mol. Pharmacol. 31:1987;585-591.
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
15. Ethell B.T., Anderson G., Beaumont K., Rance D.J., Burchell B. A universal radiochemical high performance liquid chromatographic assay for the determination of UDP-glucuronosyltransferase activity. Anal. Biochem. 225:1998;142-147.
16. Pritchard M., Fournel-Gigleux S., Siest G., Mackenzie P., Magdalou J. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol. Pharmacol. 45:1994;42-50.
17. King C.D., Rios G.R., Green M.D., Mackenzie P.I., Tephly T.R. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug. Metab. Dispos. 25:1997;251-255.
18. Green M.D., Belanger G., Hum D.W., Belanger A., Tephly T. Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein. Drug. Metab. Dispos. 25:1997;1389-1394.
19. Coffman B.L., King C.D., Rios G.R., Tephly T.R. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab. Dispos. 26:1998;73-77.
20. King C., Finley B., Franklin R. The glucuronidation of morphine by dog liver microsomes: identification of morphine-6-O-glucuronide. Drug. Metab. Dispos. 28:2000;661-663.
21. Oguri K., Hanioka N., Yoshimura H. Species differences in metabolism of codeine: urinary excretion of codeine glucuronide morphine-3-glucuronidem, and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits. Xenobiotica. 20:1990;683-688.
22. Bock K.W., Bock-Hennig B.S., Munzel P.A., Brandenburg J.O., Kohle C.T., Soars M.G., Riley R.J., Burchell B., von Richter O., Eichelbaum M.F., Swedmark S., Orzechowski A. Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by β-naphthoflavone in comparison with humans. Biochem. Pharmacol. 63:2002;1683-1690.
23. Coughtrie M.W.H., Ask B., Rane A., Burchell B., Hume R. The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme. Biochem. Pharmacol. 38:1989;3273-3280.
24. King C.D., Rios G.R., Green M.D., Tephly T.R. UDP glucuronosyltransferases. Curr. Drug. Metab. 1:2000;143-161.